JOYNTIQA Trademark

Trademark Overview


On Friday, February 17, 2023, a trademark application was filed for JOYNTIQA with the United States Patent and Trademark Office. The USPTO has given the JOYNTIQA trademark a serial number of 97800440. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 2, 2024. This trademark is owned by CENTREXION THERAPEUTICS CORPORATION. The JOYNTIQA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations in the fields of pain relief, prevention, management and treatment; veterinary preparations in the fields of pain relief, prevention, management and treatment

Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
joyntiqa

General Information


Serial Number97800440
Word MarkJOYNTIQA
Filing DateFriday, February 17, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations in the fields of pain relief, prevention, management and treatment; veterinary preparations in the fields of pain relief, prevention, management and treatment
Goods and ServicesResearch and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCENTREXION THERAPEUTICS CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02108

Party NameCENTREXION THERAPEUTICS CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02109

Trademark Events


Event DateEvent Description
Thursday, November 16, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023NEW APPLICATION ENTERED
Wednesday, March 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 2, 2024SOU EXTENSION 1 FILED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED